A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache
Sponsor
Winston Laboratories (Industry)
Overall Status
Completed
CT.gov ID
NCT00033839
Collaborator
(none)
60
26
17.9
2.3
0.1
Study Details
Study Description
Brief Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache
Study Start Date
:
Jan 1, 2002
Actual Primary Completion Date
:
Jul 1, 2003
Actual Study Completion Date
:
Jul 1, 2003
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
-
At least 2 year history of episodic cluster headache (meeting IHS criteria)
-
At least 2 previous episodes
-
Expected duration of cluster period is at least 6 weeks but not longer than 16 weeks
-
At least 1 but not more than 8 headaches on each of the 3 days immediately prior to treatment
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Valley Neurological Headache & Research Center | Phoenix | Arizona | United States | 85020 |
2 | Neurological Associates of Tucson | Tucson | Arizona | United States | 85712 |
3 | Northern California Headache Clinic | Mountain View | California | United States | 94040 |
4 | San Francisco Clinical Research Center | San Francisco | California | United States | 94109 |
5 | California Medical Clinic for Headache | Santa Monica | California | United States | 90404 |
6 | New England Center for Headache, PC | Stamford | Connecticut | United States | 06902 |
7 | Neurology Clinical Research, Inc. | Plantation | Florida | United States | 33324 |
8 | Neurology and Headache Specialists of Atlanta | Decatur | Georgia | United States | 30033 |
9 | Diamond Headache Clinic | Chicago | Illinois | United States | 60614 |
10 | Boston Clinical Research Center | Wellesley Hills | Massachusetts | United States | 02481 |
11 | Michigan Headache Pain & Neurological Institute | Ann Arbor | Michigan | United States | 48104 |
12 | Henry Ford Hospital Department of Neurology | Detroit | Michigan | United States | 48202 |
13 | Department of Neurology Mayo Clinic | Rochester | Minnesota | United States | 55905 |
14 | Mercy Health Research | Chesterfield | Missouri | United States | 63017 |
15 | Headache Care Center/Clinvest | Springfield | Missouri | United States | 65804 |
16 | Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | United States | 03756 |
17 | New York Headache Center | New York | New York | United States | 10021 |
18 | The Headache Wellness Center | Greensboro | North Carolina | United States | 27401 |
19 | Cincinnati Headache Clinic | Cincinnati | Ohio | United States | 45219 |
20 | Cleveland Clinic Foundation | Cleveland | Ohio | United States | 44195 |
21 | University of Oklahoma | Oklahoma City | Oklahoma | United States | 73104 |
22 | Neurological Associates of Tulsa, Inc. | Tulsa | Oklahoma | United States | 74136 |
23 | Jefferson Headache Center | Philadelphia | Pennsylvania | United States | 19107 |
24 | Nashville Neuroscience Center | Nashville | Tennessee | United States | 37203 |
25 | Houston Headache Clinic | Houston | Texas | United States | 77004 |
26 | The Neurology and Headache Treatment Center (Innovative Clinical Research) | Alexandria | Virginia | United States | 22304 |
Sponsors and Collaborators
- Winston Laboratories
Investigators
- Study Director: Scott B. Phillips, M.D., Winston Laboratories
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00033839
Other Study ID Numbers:
- WL-1001-02-02
First Posted:
Apr 12, 2002
Last Update Posted:
Jun 10, 2011
Last Verified:
Jun 1, 2011
Keywords provided by ,
,
Additional relevant MeSH terms: